Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rapid Dx Laboratory is a private Houston-based CLIA-certified, high-complexity molecular diagnostics laboratory that provides clinical testing services rather than developing therapeutic drug programs. The company offers genetics testing, molecular infectious disease testing, toxicology testing, general health testing, pharmacogenetics, and next-generation sequencing-based reference services for healthcare providers. It has marketed rapid-turnaround PCR and related molecular panels for areas such as gastrointestinal infections, wound and fungal pathogens, and COVID-19 testing. Rapid Dx Laboratory has also operated under the GenviewDX brand, which appears to be the company's current commercial-facing website and service identity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rapid Dx Laboratory.